Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Cesar A. Nunez Image

      Cesar A. Nunez, MD

      Department of Pediatrics, Division of Pediatrics

      Present Title & Affiliation

      Primary Appointment

      Professor, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1982Universidad de Caldas, Manizales, CO, MD

      Postgraduate Training

      1997-2000Fellowship, Pediatric Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
      1993-1997Research Associate, University of Manchester, Manchester
      1991-1993Postdoctoral Fellow, University of Alabama at Birmingham, Birmingham, Alabama
      1990-1990Visiting Scholar, University of Iowa, Iowa City, Iowa
      1986-1987Fellowship, Pediatric Hematology/Oncology, Hospital Infantil Lorencita Villegas de Santos, Santa Fe de Bogota
      1983-1986Specialization and Residency, Pediatrics, Pediatrics, Hospital Infantil Rafael Henao Toro, Universidad de Caldas, Manizales
      1982-1983Internship, Rural Medicine, Instituto de Immunologia, Santa Fe de Bogota
      1981-1982Internship, Hospital Militar Central, Santa Fe de Bogota

      Licenses & Certifications

      2000Texas Medical License

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011

      Assistant Professor (non-Tenure), Department of Pediatrics, College of Medicine, University of Tennessee, Memphis, TN, 2001 - 2004

      Assistant Member, Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, TN, 2000 - 2004

      Visiting Scholar, Department of Pathology, University of Iowa, Iowa City, IA, 1990 - 1990

      Staff Pediatrician, Pediatrics, Clinica Infantil "Colsubsidio", Bogota, 1987 - 1990

      Staff Pediatrician (non-Tenure), Pediatrics, Hospital Infantil "Torencita Villegas de Santo" Association for Prevention and Treatment of Cancer in Children (SANAR), Bogota, 1987 - 1990

      Other Professional Positions

      Education Commissioner, Latin-American Society of Pediatric Oncology (Sociedad Latino-Americana de Oncologia Pediatrica – SLAOP), Houston, TX, 2017 - 2019

      Secretary, Latin-American Society of Pediatric Oncology (Sociedad Latino-Americana de Oncologia Pediatrica – SLAOP), Houston, TX, 2014 - 2017

      Consultant Oncologist, Hospital San Jorge, Pereira, 1989 - 1990

      Other Appointments/Responsibilities, Private Pediatric Practice, Santa Fe de Bogota, 1987 - 1990

      Extramural Institutional Committee Activities

      Vice Chair, IRB-1, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Member, PRS Retirement Board, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Committee Member, Executive Committee of the Faculty Senate, The University of Texas MD Anderson Cancer Center, 2019 - 2022

      Associate Member, IRB-2, The University of Texas MD Anderson Cancer Center, 2016 - 2019

      Associate Member, IRB-1, The University of Texas MD Anderson Cancer Center, 2014 - 2016

      Faculty Senate, Senator Representative for Pediatrics, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Faculty, PRS Compensation and Benefits Advisory Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2015

      Member, Ad hoc Institutional Expense Analysis Education Subcommittee, The University of Texas MD Anderson Cancer Center, 2011 - 2016

      Committee Member, Sister Institution Network Fund (SINIF), The University of Texas MD Anderson Cancer Center, 2010 - Present

      Chair, W.W. Sutow Lecture Comittee, The University of Texas MD Anderson Cancer Center, 2009 - Present

      Committee Member, International Advisory Board, The University of Texas MD Anderson Cancer Center, 2008 - Present

      Member, Clinical Review Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2012

      Director, Pediatric Clinical and Translation Research, The University of Texas MD Anderson Cancer Center, 2007 - 2013

      Member, Global Academic Program, The University of Texas MD Anderson Cancer Center, 2005 - Present

      Member, Cancer Prevention and Control program, The University of Texas MD Anderson Cancer Center, 2003 - Present

      Editorial Activities

      Journal Reviewer, Jornal of Global Oncology, 2016 - Present

      Editorial Board, Clinical Leukemia, 2008 - 2009

      Honors & Awards

      2015 - 2018Multi-year Appointment Award, The University of Texas MD Anderson Cancer Center
      2010Pediatric Clinical and Translational Research Center at the Children's Cancer Center, Texas 4000
      1998Research Fund Competition for Clinical Trainees, The University of Texas MD Anderson Cancer Center

      Professional Memberships

      Pfizer Advisory Committee in Pediatric Oncology

      2019 - Present

      Latin-America Society of Pediatric Oncology (SLOAP)

      2014 - Present

      Southwest Oncology Group (SWOG)

      2014 - Present

      Children's Oncology Group

      2010 - Present

      Selected Presentations & Talks

      Formal Peers

      1. 2009. Lymphoma in Pediatrics. Invited. Sao Paolo, BR.
      Read More
      Less

      Grant & Contract Support

      Date: 2001 - 2002
      Title:Identification of genes involved in proliferation and cell cycle regulation of leukemic cells by gene expression microarray technology
      Funding Source:Bear Necessities Pediatric Cancer Foundation, USA
      Role:P.I
      Date: 1999 - 2000
      Title:Molecular analysis of genomic imprinting in childhood B-cell leukemias
      Funding Source:Bear Necessities Pediatric Cancer Foundation, USA
      Role:P.I
      Date: 1997 - 1998
      Title:NO TITLE PROVIDED
      Funding Source:Leukaemia Research Fund, England
      Role:Co-P.I

      Selected Publications

      Peer-Reviewed Articles

      1. Catueno, S, Frost, M, Cuglievan, B, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Malpica Castillo, LE, Garcia, MB. Uncommon Presentation and Therapeutic Strategies in Pediatric Relapsed/Refractory ALK-Positive ALCL. Journal of Pediatric Hematology/Oncology 48(3):125-127, 2026. e-Pub 2026. PMID: 41818168.
      2. Garcia, MB, Wang, B, Sheikh, IN, El Hajjar, G, McCall, DC, Nunez, CA, Gibson, A, Lorenzi, PL, Issa, GC, Cuglievan, B, Abbas, HA. High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition. Molecular and Cellular Proteomics 25(3), 2026. e-Pub 2026. PMID: 41621809.
      3. Raj, R, Catueno, S, Gibson, A, McCall, DC, Garcia, MB, Nunez, CA, Roth, M, Sasaki, K, Tewari, P, Issa, GC, Farhat, A, Connors, JS, Sheikh, IN, Nishida, Y, Yi, JS, Stevens, A, Bataller Torralba, A, Bhalla, K, Petropoulos, D, Daver, N, Kadia, TM, Cuglievan, B, DiNardo, C. FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML. Blood 146(21):2608-2611, 2025. e-Pub 2025. PMID: 40971491.
      4. Corrigan, KL, Berkman, AM, Gunther, J, Andersen, C, Wu, SY, Gibson, A, Cuglievan, B, Garcia, MB, Manzar, G, Fang, PQ, De, BS, Ahmed, S, Nunez, CA, Hildebrandt, MA, McCall, DC, Parsons, SK, Roth, M. Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiology Biomarkers and Prevention 34(9):1483-1491, 2025. e-Pub 2025. PMID: 40488452.
      5. Catueno, S, Ramakrishnan, R, Elitzur, S, Garcia, MB, McCall, DC, Nunez, CA, Roth, M, Ferrajoli, A, Cuglievan, B, Gibson, A. Lymphoid Malignancies in Ataxia–Telangiectasia. Pediatric Blood and Cancer 72(9), 2025. e-Pub 2025. PMID: 40605148.
      6. Elgehiny, A, Hsu, A, McCall, DC, Gibson, A, Cuglievan, B, Nunez, CA, Garcia, MB, Castellanos, LE, Funck, A, Razvi, S. Severe Hypertriglyceridemia Secondary to Long-acting Asparaginase in Pediatric Patients With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 47(6):e215-e221, 2025. e-Pub 2025. PMID: 40560745.
      7. Berkman, AM, Andersen, C, Puthenpura, V, Short, NJ, Merriman, K, Swaminathan, M, Cuglievan, B, McCall, DC, DiNardo, C, Nunez, CA, Jain, N, Kadia, TM, Issa, GC, Gibson, A, Garcia, MB, Andrew Livingston, J, Parsons, SK, Hildebrandt, MA, Roth, M. Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectrum 9(4), 2025. e-Pub 2025. PMID: 40579211.
      8. He, J, Munir, F, Ayerbe, C, Dickson, S, Catueno, S, Cuglievan, B, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garcia, MB, Rodriguez, NI, Cortes, JA. Managing and Preventing Hypofibrinogenemia in Pediatric and AYA Leukemia Patients. Journal of Pediatric Hematology/Oncology 47(5):235-241, 2025. e-Pub 2025. PMID: 40306291.
      9. McCall, DC, Alqahtani, S, Budak, M, Sheikh, IN, Fan, AE, Ramakrishnan, R, Nunez, CA, Roth, M, Garcia, M, Gibson, A, Daver, N, Garces, S, Short, NJ, Issa, GC, Ravandi-Kashani, F, DiNardo, C, Montalban Bravo, G, Garcia-Manero, G, Cuglievan, B, Kadia, TM. Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients. Cancers 16(22), 2024. e-Pub 2024. PMID: 39594839.
      10. Gibson, A, Dickson, S, McCall, DC, Garcia, M, Connors, JS, He, J, Roth, M, Nunez, CA, Cuglievan, B. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia. Pediatric Blood and Cancer 71(11), 2024. e-Pub 2024. PMID: 39152634.
      11. McCall, DC, Abuasab, T, Rodriguez-Sevilla, JJ, Mohamed, SF, Patnaik, A, Devireddy, K, Arani, N, Sheikh, IN, Jamshidi, R, Gibson, A, Roth, M, Nunez, CA, Garcia, M, Chien, KS, Loghavi, S, Pierce, S, Sasaki, K, Issa, GC, Cuglievan, B, Kantarjian, H, Garcia-Manero, G. Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms. Leukemia Research 144, 2024. e-Pub 2024. PMID: 39178611.
      12. He J, Garcia MB, Connors JS, Nunez CA, Quesada AE, Gibson A, Roth M, Cuglievan B, Pemmaraju N, McCall D. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. J Pediatr Hematol Oncol 45(8):e1001-e1004, 2023. e-Pub 2023. PMID: 37661300.
      13. Trabal, AM, Gibson, A, He, J, McCall, DC, Roth, M, Nunez, CA, Garcia, MB, Buzbee, M, Toepfer, L, Bidikian, A, Daver, N, Kadia, TM, Short, NJ, Issa, GC, Ravandi-Kashani, F, DiNardo, C, Montalban Bravo, G, Garces, S, Marcogliese, A, Paek, H, Dreyer, Z, Brackett, J, Redell, MS, Yi, JS, Garcia-Manero, G, Konopleva, M, Stevens, A, Cuglievan, B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients. Cancers 15(7), 2023. e-Pub 2023. PMID: 37046645.
      14. Munir, F, He, J, Connors, JS, Garcia, M, Gibson, A, McCall, DC, Nunez, CA, Dinh, CN, Robusto, L, Roth, M, Khazal, SJ, Tewari, P, Cuglievan, B. Translational advances in the treatment of childhood acute lymphoblastic leukemia. Translational Pediatrics 12(3):487-502, 2023. e-Pub 2023. PMID: 37035397.
      15. McCall, DC, Jabbour, EJ, Roth, M, Nunez, CA, Cuglievan, B. Mini-hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B-acute lymphoblastic leukemia. Pediatric Blood and Cancer 70(1), 2023. e-Pub 2023. PMID: 36031729.
      16. Ragoonanan, D, Bhar, S, Mohan, G, Beltramo, F, Khazal, SJ, Hurley, C, Andersen, C, Margossian, S, Neelapu, SS, Shpall, E, Gutierrez, C, Tewari, P, Shoberu, B, Talleur, A, McCall, DC, Nunez, CA, Cuglievan, B, Tambaro, FP, Petropoulos, D, Abdel-Azim, H, Mahadeo, KM. A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy. Frontiers in Oncology 12, 2022. e-Pub 2022. PMID: 36353531.
      17. Qiu L, Nunez CA, Tang G, Cuglievan B, Issa GC, Wang SA, Medeiros LJ, Thakral B. A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusion. Ann Hematol 101(7):1579-1581, 2022. e-Pub 2022. PMID: 35091795.
      18. Gibson, A, Trabal, AM, McCall, DC, Khazal, SJ, Toepfer, L, Bell, D, Roth, M, Mahadeo, KM, Nunez, CA, Short, NJ, DiNardo, C, Konopleva, M, Issa, GC, Ravandi-Kashani, F, Jain, N, Borthakur, G, Kantarjian, HM, Jabbour, EJ, Cuglievan, B. Venetoclax for children and adolescents with acute lymphoblastic leukemia and lymphoblastic lymphoma. Cancers 14(1), 2022. e-Pub 2022. PMID: 35008312.
      19. McCall D, Roth M, Mahadeo KM, Toepfer L, Nunez CA, Short NJ, Daver NG, Kadia TM, DiNardo CD, Yi JS, Cuglievan B. Gilteritinib Combination Therapies in Pediatric Patients with FLT3 Mutated Acute Myeloid Leukemia. Blood Adv, 2021. e-Pub 2021. PMID: 34592761.
      20. Baig MU, Rytting M, Roth M, Morani AC, Nunez CA, Lin P, Cuglievan B. Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma. J Pediatr Hematol Oncol 43(7):e991-e996, 2021. e-Pub 2021. PMID: 33480649.
      21. Vasquez L, Sampor C, Villanueva G, Maradiegue E, Garcia-Lombardi M, Gomez-Garcia W, Moreno F, Diaz R, Cappellano AM, Portilla CA, Salas B, Nava E, Brizuela S, Jimenez S, Espinoza X, Gassant PY, Quintero K, Fuentes-Alabi S, Velasquez T, Fu L, Gamboa Y, Quintana J, Castiglioni M, Nunez CA, Moreno, A, Luna-Fineman S, Luciani S, Chantada G. Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America. Lancet Oncol 6:753-755, 2020. e-Pub 2020.
      22. Tambaro FP, Khazal S, Nunez CA, Ragoonanan D, Tewari P, Petropoulos D, Kebriaei P, Wierda WG, Mahadeo KM. Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy. Clin Case Rep 8(9):1678-1681, 2020. e-Pub 2020.
      23. Nunez CA, Hassinger AB. Predictors of Negative Pressure Ventilation Response in Pediatric Acute Respiratory Failure. Respir Care 65(1):91-98, 2020. e-Pub 2020. PMID: 31575711.
      24. Jain N, Lu X, Daver N, Thakral B, Wang SA, Konoplev S, Patel K, Kanagal-Shamanna R, Valentine M, Tang G, Pemmaraju N, Jorgensen J, Kebriaei P, Nunez CA, Wierda W, Jabbour E, Roberts KG, Mullighan CG, Kantarjian H, Konopleva M. Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients. Haematologica:e514-e517, 2017. e-Pub 2017.
      25. Lewis DJ, Turkeltaub AE, Dai J, Nagarajan P, Rieger KE, Nunez CA, Kim YH, Duvic M. An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with prednisone. JAAD Case Rep:276-279, 2017. e-Pub 2017.
      26. Aitken SL, Kontoyiannis DP, DePombo AM, Bhatti MM, Tverdek FP, Gettys SC, Nicolau DP, Nunez CA. Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient. Pediatr Infect Dis J 35(9):1040-2, 2016. e-Pub 2016. PMID: 27254038.
      27. Chemaly RF, Ghantoji SS, Shah DP, Shah JN, El Taoum KK, Champlin RE, Nunez CA, Mulanovich V, Ariza-Heredia E. Respiratory Syncytial Virus Infections in Children with Cancer. J Pediatr Hematol Oncol 36(6):376 - 381, 2013. PMID: 24327130.
      28. Fanale M, Fayad L, Pro B Samaniego F, Liboon MF, Nunez CA, Horowitz S, Anderlini P, Popat U, Ji Y, Kwak LW, Younes A. Phase I Study of Bortezomib Plus ICE(BICE) for the Treatment of Relapsed/Refractory Hodgkin Lymphoma. British Journal Haematology 154(2):284 -286, 2011. e-Pub 2011. PMID: 21517809.
      29. Sakhinia E, Weaver DL, Nunez CA, et al.. Single cell RT-PCR cDNA subtraction. Methods in Molecular Biology(461):667 - 674, 2008. e-Pub 2008.
      30. Hudson MM, Rai SN, Nunez CA, et al.. Non-invasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. Journal of Clinical Oncology 25(24):3635 - 3643, 2007. e-Pub 2007.
      31. Hijiya N, Metzger ML, Pounds S, Schmidt JE, Razzouk BI, Rubnitz JE, Howard SC, Nunez CA, Pui C-H, Ribeiro RC. Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia. Pediatr Blood Cancer(44):63 - 69, 2005. e-Pub 2005.
      32. Nunez CA, Zipf TF, Roberts WM, Medeiros LJ, Hayes K, Bueso-Ramos CE. Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia. Arch Pathol 127(5):601 - 605, 2003. e-Pub 2003. PMID: 12708906.
      33. Nunez CA, Bashein AM, Brunet CL, Hoyland JA, Freemont A, Buckle AM, Murphy C, Cross M, Lucas G, Bostock VJ, Brady G. The imprinted tumor-supressor gene H19 is regulated during normal haemopoiesis and is reduced in haemopoietic precursors of patients with polycythemia vera. J Pathol(190):61 - 68, 2000. e-Pub 2000.
      34. Shiokawa S, Mortari F, Lima J, Nunez CA, Bertrand III FE, Kirkham P, Zhu S, Schroeder HW. Multiple mechanisms are used to actively limit the expression of long immunoglobulins HCDR3 intervals during fetal life. J Immunol(162):6060 - 6070, 1999. e-Pub 1999.
      35. Weaver D, Nunez CA, Brunet C, Bostock V, Brady G. Single-cell RT-PCR cDNA subtraction. Methods Mol Biol(97):601 - 609, 1999. e-Pub 1999.
      36. Bueso-Ramos C, Medeiros LF, Zipf T, Nunez CA, Tubergen D. Tubergen D. Tenupodia formation by blasts in bone marrow aspirate smears from a patient with acute monoblastic leukemia. Blood(94):3954 - 3955, 1999. e-Pub 1999.
      37. Chan KW, Békássy AN, Ha CS, Nunez CA, Alvegård TA, Sallerfors B. Fludarabine-based preparative protocol for unrelated donor cord blood transplantation in children: successful engraftment with minimal toxicity. Bone Marrow Transplant 23(8):849 - 851, 1999. e-Pub 1999. PMID: 10231153.
      38. Nunez R, Sanchez M, Wild P, Filgueira L, Nunez CA. Characterization of two human dendritic cell-lines that express CD1a, take-up, process and present soluble antigens and induce MLR. Immunol Lett(61):31 - 43, 1998. e-Pub 1998. PMID: 9562373.
      39. Nunez CA, Nishimoto N, Gartland GL, Kubagawa H, Cooper MD. B-lineage cells are generated throughout life in humans. J Immunol(156):866 - 872, 1995. e-Pub 1995.
      40. Billips L, Nunez CA, Bertrand III FE, Stankovic AK, Gartland GL, Burrows PD, Cooper MD. Antagonist Effect of interleukin-7 and CD19 on immunoglobulin recombinase gene activity in B cell progenitors. J Exp Med(182):973 - 982, 1995. e-Pub 1995.
      41. Lassoued K, Nunez CA, Billips L, Kubagawa H, Monteiro RC, Lebien TW, Cooper MD. Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell(73):73-86, 1993. e-Pub 1993.
      42. Nunez R, Munoz R, Nunez CA, de Gomez B. A micro-ELISA for the diagnosis of cerebral cisticercosis. J Immunoassay, 1989. e-Pub 1989.
      43. Nunez R, Raad J, Nunez CA. Antibodies against spermatozoids in homosexual, AIDS patients and sterile men. Allergologia et Immunopathology 215(15):17, 1987. e-Pub 1987.
      44. Nunez R, Raad J, Nunez CA. Antibodies against spermatozoids in homosexuals and AIDS patients. Acta Medica Colombiana 11:169, 1986. e-Pub 1986.
      45. Nunez R, Nunez CA, Sanchez M. Pediatric respiratory semiology. Medicina de Caldas (Colombia)(5):39-53, 1985. e-Pub 1985.
      46. Nunez R, Nunez CA, Sanchez M. Recurring infection syndrome. Pediatria (Colombia) 21(11):36, 1985. e-Pub 1985.
      47. Nunez R, Nunez CA, Sanchez M. Hypogammaglobulinemia A. Pediatria (Colombia)(20):15-23, 1984. e-Pub 1984.
      48. Nunez R, Raad J, Nunez CA, Duque J, Orduz A. Low lymph counts in homosexuals. Pediatria (Colombia)(4):7-13, 1984. e-Pub 1984.
      49. Nunez R, Nunez CA, Sanchez M. Necrotic enterocolitis. Medicina de Caldas (Colombia) 4(60):3, 1984. e-Pub 1984.

      Review Articles

      1. McCall D, Catueno S, Ramakrishnan R, Tewari P, Sheikh I, Gibson A, Nunez CA, Garcia MB, Cuglievan B. Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in Pediatric Acute Lymphoblastic Leukemia. Acta Haematol 149(1):1-16, 2025. e-Pub 2025. PMID: 40324358.
      2. Cuglievan, B, Kantarjian, HM, Rubnitz, JE, Cooper, T, Zwaan, CM, Pollard, J, DiNardo, C, Kadia, TM, Guest, E, Short, NJ, McCall, DC, Daver, N, Nunez, CA, Haddad, FG, Garcia, MB, Bhalla, K, Maiti, A, Catueno, S, Fiskus, WC, Carter, BZ, Gibson, A, Roth, M, Khazal, SJ, Tewari, P, Abbas, HA, Bourgeois, W, Andreeff, M, Shukla, N, Truong, D, Connors, JS, Ludwig, JA, Stutterheim, J, Salzer, E, Juul-Dam, KL, Sasaki, K, Mahadeo, KM, Tasian, SK, Borthakur, G, Dickson, S, Jain, N, Jabbour, EJ, Meshinchi, S, Garcia-Manero, G, Ravandi, F, Stein, EM, Kolb, EA, Issa, GC. Menin inhibitors in pediatric acute leukemia. Leukemia 38(10):2073-2084, 2024. e-Pub 2024. PMID: 39179671.
      3. He, J, Munir, F, Catueno, S, Connors, JS, Gibson, A, Robusto, L, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garces, S, Cuglievan, B, Garcia, MB. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473221.
      4. Cuglievan, B, Connors, JS, He, J, Khazal, SJ, Yedururi, S, Dai, J, Garces, S, Quesada, AE, Roth, M, Garcia, M, McCall, DC, Gibson, A, Ragoonanan, D, Petropoulos, D, Tewari, P, Nunez, CA, Mahadeo, KM, Tasian, SK, Lamble, AJ, Pawlowska, A, Hammond, DE, Maiti, A, Haddad, FG, Senapati, J, Daver, N, Gangat, N, Konopleva, M, Meshinchi, S, Pemmaraju, N. Blastic plasmacytoid dendritic cell neoplasm. Leukemia 37(9):1767-1778, 2023. e-Pub 2023. PMID: 37452102.

      Other Articles

      1. Samra B, Kantarjian HM, Sasaki K, Alotaibi AS, Konopleva M, O'Brien S, Ferrajoli A, Garris R, Nunez CA, Kadia TM, Short NJ, Jabbour E Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Postive Acute Lymphoblastic Leukemia outside of Transplant. Acta Haematol 144(3):1-8, 2020. PMID: 33238260.
      2. Kim EJ, Aria AB, Wilmas K, Lewis DJ, Torres-Cabala CA, Nunez CA, Dabaja BS, Duvic M Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation. Pediatr Dermatol 36(1):e23-e26, 2018. PMID: 30548331.

      Editorials

      1. Okeleji, O, McCall, DC, Gibson, A, Garcia, MB, Nunez, CA, Roth, M, Connors, JS, Petropoulos, D, Tewari, P, Cuglievan, B, Sheikh, IN. Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia. Blood Advances 9(8):1988-1990, 2025. PMID: 39993239.

      Abstracts

      1. Sheikh, I, Sarkar, S, Jain, T, Gibson, A, Trabal, A, Toepfer, L, Bell, D, McCall, D, Nunez, C, Roth, M, Cuglievan, B. Nodular Lymphocyte Predominant Hodgkin Lymphoma in Aya, Md Anderson Cancer Center’s 20-Year Experience. ASPHO, 2021. e-Pub 2021.
      2. Wahba, A, Toepfer, L, Bell, D, Roth, M, McCall, D, Nunez, C, Cuglievan, B. Synchronous Leukemia and Ependymoma In A Pediatric Patient With No Genetic Predisposition. ASPHO, 2021. e-Pub 2021.
      3. Sarkar, S, Sheikh, I, Jain, T, Gibson, A, Trabal, A, Toepfer, L, Bell, D, McCall, D, Roth, M, Nunez, C, Cuglievan, B. Impact Of Body Mass Index (BMI) On Overall Relapse Of Classical Hodgkin Lymphoma. ASPHO, 2021. e-Pub 2021.
      4. Jain, T, Sheikh, I, Sarkar, S, Gibson, A, Trabal, A, Toepfer, L, Bell, D, McCall, D, Nunez, C, Roth, M, Cuglievan, B. Risk Factors For 3rd Or Greater Relapses in AYA Patients With Classical Hodgkin Lymphoma: The MD Anderson Cancer Center Experience. ASPHO, 2021. e-Pub 2021.
      5. Sheikh, I, Sarkar, S, Jain, T, Gibson, A, Trabal, A, Toepfer, L, Bell, D, McCall, D, Nunez, C, Roth, M, Cuglievan, B. AYA patients with Mixed Cellularity Classical Hodgkin Lymphoma: The Md Anderson Cancer Center, 20-Year Experience. ASPHO, 2021. e-Pub 2021.
      6. Samra B, Kantarjian H, Sasaki K, Konopleva M, Kouri R, O’Brien S, Ferrajoli A, Nunez CA, Kadia TM, Jabbour E. Discontinuation of tyrosine kinase inhibitors (TKI) in Philadelphia-Chromosome (Ph+) acute lymphoblastic leukemia. 61th ASH Meeting 2019, Orlando, FL, Winner of 2019 ASH Abstract Achievement Award, 2019. e-Pub 2019.
      7. Cuglievan B, Roth M, Triche L, Bell DA, Toepfer L, Chasen B, Nunez C, Lin P, and Rytting M. Major response to Venetoclax and Decitabine in a patient with refractory T-cell lymphoblastic lymphoma. SIOP 51th Annual Meeting, Lyon, France, 2019. e-Pub 2019.
      8. Wieser I, Wohlmuth C, Nunez CA, Duvic M. Lymphomatoid Papulosis in Children and Adolescents: A Systematic Review. Am J Clin Dermatol 17(4):319-27, 2016. e-Pub 2016. PMID: 27138554.
      9. Bell DA, Young K, Rao Syamasudbar P, Nunez C. Concomitant presentation of Kawasaki disease and Hodgkin lymphoma: An unusual presentation, 2014. e-Pub 2014.
      10. Moonat H, Maher O, Nunez C, Hu S, Khatua S, Zaky W. Infections mimicking malignancy; report of two cases of abdominal tuberculosis and acute EBV infection simulating neoplasm. 27th Annual Meeting ASPHO, Chicago, IL, 2014. e-Pub 2014.
      11. Corrales-Medina F, Herzog CE, Egas-Bejar D, Hess K, Huh W, Anderson P, Hong D, Nunez C, Kleinerman ES, Kurzrock R, Vivek S. Clinical characterisitcs and outcomes of Pediatric Oncology Patients with aggressive biology enrolled in Phase I clinical trials designed for adults. 27th Annual Meeting ASPHO, Chicago, IL, 2014. e-Pub 2014.
      12. Janko F, Garrido-Laguna I, Velez-BRavo VM, Falchook GS, Subbiah V, Hong DS, Oki Y, Westin JR, Nunez CA, Fayad LE, Kwak LW, Sphall EJ, Wheler JJ, Liang W, Salhia B, Eric-Bernstam FM, Kurzrock R, Fanale MA. Significant activity of the mTOR inhibitor sirolimus and HDAC inhibitor vorinostat in heavily pretreated refractory Hodgkin lymphoma patients. 2nd International Symposium, Berlin, Germany, 2014. e-Pub 2014.
      13. Janku F, Garrido-Laguna I, Velez-Bravo VM, Falchook GS, Subbiah V, Hong DS, Oki Y, Westin JR, Nunez CA, Fayad LE, Kwak LW, Shppall EJ, Wheler JJ, Liang W, Salhia B, Meric-Bernstam F, Kurzrock R, Fanale MA. Significant activity of the mTOR inhibitor sirolimus and HDAC inhibitor vorinostat in heavily pretreated refractory Hodgkin lymphoma patients. Blood, 2013. e-Pub 2013.
      14. Rytting M, Thomas D, Franklin A, Wells R, Zweidler-McKay P, Schroeder K, Nunez C, Jabbour E, Faderl S, Ravandi F, O'Brien S, Kantarjian H. Augmented Berlin-Frankfurt-Munster in adolescents and young adults with acute lymphoblastic leukemia. Pediatric Blood and Cancer, 2010. e-Pub 2010.
      15. Fanale MA, Faad LE, Pro B, Samaniego F, Zachariah G, Nunez CA, Ji Y, Younes A. A Phase I Study of Bortezominib in combination with ICE (BICE) in patients with relapsed/refractory classical Hodgkin lymphoma. Blood, 2008. e-Pub 2008.
      16. Levy AG, Sabell-River R, Ghisoli ML, Nunez CA, Anderson PM, Palla SL, De Angulo G, Zwedlier-Mckay P. ASH Annual meeting 2008. Blood, 2008. e-Pub 2008.
      17. Rytting M, Thomas D, Kantarjian H, Cortes J, Borthakur G, Wierda W, Nunez C, Kornblau S, Ravandi F, Wells R, Muriera B, Franklin A, O'Brien S. Adaptation of Augmented Berlin-Frandjurt-Munster (ABFM) therapy in adolescents and young adults with acute lymphoblastic leukemia (ALL). Blood, 2007. e-Pub 2007.
      18. Fanale MA, Fayad LE, Pro B, Samaniego F, Zachariah G, Nunez CA, Ji Y, Younes A. Safety and efficacy of Bortexomib pluse ICR (BICE) for the treatmetn of relpased/refractory classical Hodgkin's lymphoma. Blood, 2007. e-Pub 2007.

      Letters to the Editor

      1. Cohen, E, Okeleji, O, McCall, DC, Garcia, MB, Nunez, CA, Cuglievan, B, Herzog, CE, Razvi, S, Tewari, P, Douglas, H, Gibson, A. Synchronous Mediastinal Germ Cell Tumor with Sarcomatous Transformation and Acute Myeloid Leukemia. Pediatric Blood and Cancer 72, 2025.
      2. Sheikh, IN, Uwaezuoke, D, Okeleji, O, Quesada, AE, Herzog, CE, Ragoonanan, D, Tewari, P, Petropoulos, D, McCall, DC, Nunez, CA, Roth, M, Cuglievan, B, Khazal, SJ. Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation. Pediatric Blood and Cancer 72, 2025.
      3. Nash, A, Dinh, CN, Kawedia, J, McCall, DC, Weinman, S, Garcia, M, Roth, M, Nunez, CA, Cuglievan, B, Gibson, A. Calasparagase Pegol Induced Hemolytic Anemia. Pediatric Blood and Cancer 72, 2025.
      4. Nash, A, Weirda, WG, Albritton, KH, Cuglievan, B, Garcia, MB, McCall, DC, Nunez, CA, Gibson, A. Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy. Pediatric Blood and Cancer 71, 2024.
      5. Gibson, A, Nunez, CA, Robusto, L, Kammerer, B, Garcia, M, Roth, M, Sheth, RK, Tewari, P, Hittle, A, Toepfer, L, Torres, R, Short, NJ, Jabbour, EJ, Jain, N, Cuglievan, B, McCall, DC. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica 109: 3042-3047, 2024.
      6. Okeleji, O, Gibson, A, Nunez, CA, Garcia, MB, Roth, M, Cuglievan, B, McCall, DC. Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma. Pediatric Blood and Cancer 71, 2024.
      7. Alqahtani, S, Ramakrishnan, R, Shuyu, E, Wang, S, Nunez, CA, McCall, DC, Garcia, MB, Roth, M, Cuglievan, B, Gibson, A. Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia. Pediatric Blood and Cancer 71, 2024.
      8. Sarkar, S, Rav, ES, Stitzlein, LM, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Ragoonanan, D, Connors, JS, Herzog, CE, Cuglievan, B, Garcia, MB. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia. Pediatric Blood and Cancer 71, 2024.
      9. Sheikh, IN, Alqahtani, S, Yin, CC, McCall, DC, Cuglievan, B, Ragoonanan, D, Connors, JS, Gibson, A, Nunez, CA, Roth, M, Ohanian, M, Borthakur, G, Garcia, MB. KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatric Blood and Cancer 71, 2024.
      10. Rav, ES, Wahba, A, Patnaik, A, Toruner, GA, Hittle, A, Toepfer, L, Roth, M, Cuglievan, B, Nunez, CA, McCall, DC. A balancing act. Pediatric Blood and Cancer 70, 2023.
      11. Sheikh, IN, Nunez, CA, McCall, DC, Roth, M, Cuglievan, B. Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient. Pediatric Blood and Cancer 69, 2022.
      12. Kohorst MA, Nunez CA, Tewari P, Petropoulos D, Mahadeo KM, Neelapu SS, Shpall EJ, Khazal S. Primary mediastinal large B-cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy. Br J Haematol 190: e114-e117, 2020.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top